Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Glaukos (GKOS) R&D In Process (2017 - 2022)

Glaukos (GKOS) has disclosed R&D In Process for 4 consecutive years, with $10.0 million as the latest value for Q2 2022.

  • Quarterly R&D In Process rose 100.0% to $10.0 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2022, up 50.0% year-over-year, with the annual reading at $10.0 million for FY2022, 0.0% changed from the prior year.
  • R&D In Process for Q2 2022 was $10.0 million at Glaukos, up from $5.0 million in the prior quarter.
  • The five-year high for R&D In Process was $10.0 million in Q2 2022, with the low at $1.5 million in Q3 2019.
  • Average R&D In Process over 3 years is $4.7 million, with a median of $5.0 million recorded in 2021.
  • Peak annual rise in R&D In Process hit 100.0% in 2022, while the deepest fall reached 100.0% in 2022.
  • Over 3 years, R&D In Process stood at $1.5 million in 2019, then skyrocketed by 233.33% to $5.0 million in 2021, then soared by 100.0% to $10.0 million in 2022.
  • According to Business Quant data, R&D In Process over the past three periods came in at $10.0 million, $5.0 million, and $5.0 million for Q2 2022, Q3 2021, and Q2 2021 respectively.